Regulatory chatter on commissions puts insurance stocks under the lens

Speculation about changes to insurance commissions is back on Dalal Street. This is raising concerns for distributors and insurers. Analysts warn that stock prices might not fully reflect these potential regulatory shifts. While the December quarter shows strong momentum for insurers, especially in health and term plans, any commission cuts could hurt volumes. Policybazaar also faces uncertainty.